Genedata Biopharma Platformは、業界を牽引する世界中のバイオファーマ企業、バイオテクノロジー企業、CRO・CDMOにおいて、研究・開発・製造を自動化・デジタル化し、革新的な医薬品の創出を加速しています。
6つのソリューション、1つのプラットフォーム
Genedataのソフトウェアソリューションは、独立してあるいは組み合わせて運用でき、ビジネスへ大きなメリットを提供します。
Reduce Compound Screening Analysis Times From 3 Days to 3 Hours.
Software Benefits:
- Automate data capture, processing, analysis, and reporting
- Scale up complex assays for execution earlier in the discovery chain
- Use real-time feedback for rapid project decisions, to adapt or course-correct
- Harmonize analysis across instruments and labs
- Standardize and automate quality control
- Structure results within assay context
- Ensure data traceability and accessibility
- Employ cutting-edge assay technologies, including multiplexed and label-free
- Perform deep, scientifically-appropriate analysis using smart fitting and model selection
- Automate routine analyses with AI/ML-based methods
Increase Bioengineering Output by a Factor of 10.
Software Benefits:
- Register All Biotherapeutic Modalities
- E2E Support for Complex Workflows
- Automate Instrument Integration Workflows
- Integrated Assessment & Decision Support
- Internal And External (CRO) Collaboration
- Data Integrity & Traceability
Increase Process Development Efficiency by 200%.
Software Benefits:
- E2E Bioprocess Development
- Regulatory Compliance
- Quality By Design
- Instrument Integration & Process Automation
- Internal And External (CDMO) Collaboration
- Digital Twin / Modeling
Increase Efficiency by Eliminating >90% of Manual Data Processing Hours.
Software Benefits:
- Streamlined Mass Spec Workflows
- In-Depth Molecular Characterization
- Comprehensive Process Monitoring
- Automated & Custom Data Processes
- Robust & Flexible
- MAM Implementations
- GXP-Ready Product Quality Assessment
Reduce Assay Time of NGS Workflows for Product Characterization by 90%.
Software Benefits:
- NGS-Based Workflow Automation
- Proprietary Genome Annotation
- CRISPR-based Target Engineering
- Development of Stable Cell Lines
- Critical Quality Attributes (CQA) & MAM Assessment
- Optimize Bioprocess With -Omics Data
- Biosafety Testing In GMP Environment
Design Smarter Clinical Trials to Improve the Success Rate by 20%.
Software Benefits:
- Identify New Therapies
- Define New Therapeutic Indications
- Discover/Validate Novel Biomarkers
- Leverage Real World Data
- Design Smarter, Targeted Clinical Trials
- Enable Precision Medicine
Automating Biotherapeutic Characterization
Discover how automated MS data workflows enhance productivity, harmonize analysis, eliminate errors, and facilitate collaboration in biopharmaceutical developability assessments at Novartis.
Data Backbone Connects R&D Organization
“Now that we have a central data backbone in place where all information can be accessed and shared, our R&D groups can spend their time on critical scientific tasks, instead of manual data reporting and management.”